Clinical Trial Update: Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the effectiveness and safety of reconstructing the maxilla alveolar process using synthetic tricalcium phosphate and autol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Atrophy
• Alveolar Bone Loss
• Partial Edentulism

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)
• Synthetic Tricalcium Phosphate (tricalcium phosphate)

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Partially Edentulous Maxilla, Alveolar Bone Atrophy | Phase 1, Phase 2 | Status: UNKNOWN